好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Acute Ischemic Stroke in the Setting of Acute Posterior Multifocal Placoid Pigment Epitheliopathy
Autoimmune Neurology
Autoimmune Neurology Posters (7:00 AM-5:00 PM)
048

Introduction

Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) is an immune-mediated chorioretinal disease causing acute visual symptoms predominantly in young adults. Central nervous system involvement is a rare manifestation, and CNS vasculitis is associated with increased mortality and morbidity. Patients with APMPPE who develop CNS manifestations should begin immunosuppressive therapy immediately to prevent further neurological complications. Here we discuss an interesting presentation of APMPPE in a young woman who developed acute ischemic stroke as a CNS complication.

Case Presentation

A 28-year-old woman developed progressive binocular blurry vision over the course of several months and was diagnosed with APMPPE on color fundus photography (Figure 1). A few months later, she presented to the ED with acute onset of right-sided weakness, sensory symptoms, and expressive aphasia. CT angiogram showed multifocal stenoses concerning for cerebral vasculitis (Figure 2). MRI showed multi-territorial infarcts and multiple enhancing leptomeningeal lesions (Figure 3). Lumbar puncture showed a lymphocytic pleocytosis. Leptomeningeal biopsy showed lymphocytic infiltrates. She received pulse steroids followed by long-term azathioprine treatment and recovered neurologically.

Clinical Impacts/Relevance

This case adds to the literature of rare but serious neurological complications of APMPPE, such as cerebral vasculitis. It highlights the need for a high level of suspicion as early treatment with immunosuppressive therapy can improve the outcomes.

Discussion

APMPPE is a rare immune-mediated chorioretinal disease that can present with fatal CNS complications. Physicians should carry a high index of suspicion for such CNS complications including cerebral vasculitis because it is imperative to begin early therapy with immunosuppressive

NA

NA

NA

NA
Authors/Disclosures
Leila Ghaffari, MD (VCU Health System)
PRESENTER
Dr. Ghaffari has nothing to disclose.
Osamah Alnasser, MD (Carilion Clinic) Dr. Alnasser has nothing to disclose.
Yakov Shaulov, MD (Optum) Dr. Shaulov has nothing to disclose.
Aleksey Tadevosyan, MD (Lahey Clinic) Dr. Tadevosyan has nothing to disclose.
Joseph D. Burns, MD (Lahey Hospital and Medical Center) Dr. Burns has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Ritu Bagla, MD (Lahey Hospital and Medical Center) Dr. Bagla has nothing to disclose.
Jayashri Srinivasan, MD, PhD, MRCP, FAAN (Lahey Clinic) Dr. Srinivasan has nothing to disclose.
No disclosure on file